Amie Lynn Lambermon-Phinney Insider Profile
4 Followers
Amie Lynn Lambermon-Phinney, Director at Defence Therapeutics, holds 16.33K shares in Defence Therapeutics (Ticker: DTCFF). Most recently, Amie Lynn Lambermon-Phinney Bought 16,333 shares of Defence Therapeutics on Oct 24, 2026 for an estimated value of $6.27K.
Amie Lynn Lambermon-Phinney's Trading History
| DTCFFDefence Therapeutics | Oct 24, 2026 | Director | Informative Buy | 6.27K | $3.25K | |||||||||||||||
DTCFF Insider Shares: 16.33K (2.85%)
| ||||||||||||||||||||
You May Also Like
Amie Lynn Lambermon-Phinney insider profile FAQ
What stocks does Amie Lynn Lambermon-Phinney hold?
Amie Lynn Lambermon-Phinney holds: DTCFF stocks.
What was Amie Lynn Lambermon-Phinney’s latest transaction?
Amie Lynn Lambermon-Phinney’s latest transaction was an Informative Buy of $6.27K.
What is Amie Lynn Lambermon-Phinney's role in Defence Therapeutics?
Amie Lynn Lambermon-Phinney's role in Defence Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.